Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis. - Wikidata - awgldk - TriplyDB

Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis.

Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis.

http://www.wikidata.org/entity/Q37711313

about

Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.

P2860

Q39397055-C079947C-C78C-4ED8-B51D-DEE32504DE76

P2860

Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis.

http://www.wikidata.org/entity/Q37711313

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@en

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@nl

type

label

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@en

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@nl

prefLabel

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@en

Cardioprotective Effects of Or ...... ion Treated with Thrombolysis.

@nl

P1433

Q37711313-82B03DEB-BF32-42C6-A8F6-D0A12E281B4D

P1476

Q37711313-B7E80EE3-99B6-4857-8D69-7A099BD555F8

P2093

Q37711313-1DA57ACE-4DA1-4D48-A0DF-BFE759B44E84

P2860

Q37711313-03EC5160-891D-4BAB-BB6F-23EADA1EBC30

Q37711313-1720992B-0491-4D94-AED0-0C91C4CDCC97

Q37711313-1ED62976-7A73-4293-9B36-8A0F71A539C8

Q37711313-1F177F74-D638-4510-A767-31C8C0FCF153

Q37711313-2162BBAE-B158-4E8F-BAC7-8EC3835FE7C5

Q37711313-25558034-F60A-4203-AE22-BB9D141ADB43

Q37711313-3A157ADC-4D6D-44F3-960D-3C436EC62B9B

Q37711313-4753C9EE-A6E8-4311-BED2-9E656C3D6540

Q37711313-4B5D9CFC-4BCF-4039-BA88-C33B8614410F

Q37711313-5536D05D-EA16-45CC-A8E9-F12CD7E179DA

P304

Q37711313-E2149C41-A017-4158-8008-D8E769B4468B

P31

Q37711313-FC6C8C92-A984-4A18-A590-C571DFDD5790

P356

Q37711313-A8515055-1BEF-4300-B3F3-F262041DF795

P433

Q37711313-1F73E1FC-E40A-4E55-8433-25D8E16240D5

P478

Q37711313-0A22F619-F823-4CCB-A873-88D28D7C41AC

P50

Q37711313-B7C9CB91-D562-4DB7-9182-C634C7B9FE40

P577

Q37711313-8F88F283-22D1-4797-ABAE-E49B291C5115

P698

Q37711313-F53A091F-78B3-4FA2-BDA5-CCB1AE3662DD

P921

Q37711313-664ACB4A-A0E1-447D-9283-633237242C2F

Q37711313-AE7E5790-4078-479F-A006-54F35B7F42D1

P932

Q37711313-625C6F4F-577E-449A-96BC-E29231E4FB11

P356

P1433

Cardiology research

P1476

Cardioprotective Effects of Or ...... tion Treated with Thrombolysis

@en

P2093

Mohamed Shehata

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty

Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction.

Reversible left ventricular dysfunction.

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Coronary reperfusion rates in acute myocardial infarction patients after thrombolytic treatment with anistreplase: correlation with the delay from onset of symptoms to treatment: a review of 424 case records of patients admitted to coronary reperfus

P304

58-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/CR330W

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed Shehata

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28392876

http://www.w3.org/2001/XMLSchema#string

P921

P932

5358175

http://www.w3.org/2001/XMLSchema#string